HOME > TOP STORIES

TOP STORIES

ACADEMIA JCS’s 2013 Guidelines for Treatment of AF Recommend Dabigatran and Apixaban in Moderate-Risk Patients

January 29, 2014
REGULATORY MHLW Setting Out on Development of iPS Tech-Based Cardiotoxicity Evaluation

January 28, 2014
BUSINESS Ajinomoto to Downsize In-House Drug Discovery Research amid Slack Pharma Biz

January 27, 2014
BUSINESS Novartis Used Interim Report of “Sign” Trial in Tasigna Promotion, Set to Probe Its Involvement in Protocol Drafting

January 24, 2014
BUSINESS Novartis Adds LABA/LAMA Combination Ultibro to Lineup of Breezhaler Products for COPD Using the Same Inhaler

January 24, 2014
REGULATORY DPP-4 Inhibitors, Remicade to Face Market Expansion Re-Pricing in FY2014 Revision

January 23, 2014
BUSINESS Azilva Remains No.1 in December “Mind Share” Ranking in GP, HP Markets

January 22, 2014
BUSINESS Sales Reps Vied over Questionnaire Transfers in Tasigna Trial, Boss OK’ed Incentive Program: Novartis

January 21, 2014
BUSINESS Novartis Sales Reps Transferred Patient Questionnaires in Investigator-Led Trial

January 20, 2014
BUSINESS Japan’s First SGLT-2 Inhibitor Suglat Approved: Astellas

January 20, 2014
REGULATORY More Manpower, Knowledge Necessary for Giving New Drugs World’s First Approval: PMDA Chief Executive

January 17, 2014
REGULATORY Varicella, Adult Pneumococcal Vaccines to Join Japan’s Routine Immunization Program in October

January 16, 2014
ORGANIZATION Generic Makers Likely to Disclose Payments to Medical Institutions from Early May

January 15, 2014
ORGANIZATION JPWA Chair Weighs Cartel Deal to Unify Tax Display Methods after Sales Levy Hike

January 14, 2014
REGULATORY Did Novartis Employees “Willfully” Use Rigged Data in Diovan Ads? Statute of Limitations Will Pose Hurdles to Chase Key Figure

January 10, 2014
ORGANIZATION Next Drug Price Revision Won’t Help Promote Generic Use, JGA President Says

January 9, 2014
REGULATORY MHLW Files Criminal Complaint against Novartis over Diovan Ads

January 9, 2014
BUSINESS Former Pfizer EPBU Head Matsumori Joins SBI Biotech as President

January 8, 2014
REGULATORY MHLW to File Criminal Complaint against Novartis Jan. 8

January 8, 2014
REGULATORY MHLW Economic Affairs Official Says Shakeout in Generic Sphere “Inevitable”

January 7, 2014

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Pharma Renews Call to Scrap “Spillover,” “Huge-Seller” Rules as FY2026 Talks Enter Final Stretch

By Ken Yoshino

Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…